Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ChiCTR2600126428Phase 4Not yet recruiting
Phase 4, randomised trial in anxiety disorder and None comparing Propofol group with Remimazolam + fospropofol disodium group (2 arms). Primary endpoint: Time to reach MOAA/S score of 1. Planned start Jun 2026; status: not yet recruiting.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on ChiCTR2600126428.